메뉴 건너뛰기




Volumn 29, Issue 32, 2011, Pages 5221-5231

Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine

Author keywords

Intranasal delivery; Mucoadhesive; Norovirus vaccine; Spray dry powder formulation; TLR agonist; Virus like particles (VLP)

Indexed keywords

ALOE VERA EXTRACT; GELSITE; GELVAC; POLYGALACTURONIC ACID; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE;

EID: 79960323464     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.027     Document Type: Article
Times cited : (81)

References (59)
  • 2
    • 48749116831 scopus 로고    scopus 로고
    • Systematic literature review of role of noroviruses in sporadic gastroenteritis
    • August
    • Patel M.M., Widdowson M.A., Glass R.I., Akazawa K., Vinje J., Parashar U.D. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008, 14(August (8)):1224-1231.
    • (2008) Emerg Infect Dis , vol.14 , Issue.8 , pp. 1224-1231
    • Patel, M.M.1    Widdowson, M.A.2    Glass, R.I.3    Akazawa, K.4    Vinje, J.5    Parashar, U.D.6
  • 3
    • 70350553836 scopus 로고    scopus 로고
    • Norovirus gastroenteritis
    • October
    • Glass R.I., Parashar U.D., Estes M.K. Norovirus gastroenteritis. N Engl J Med 2009, 361(October (18)):1776-1785.
    • (2009) N Engl J Med , vol.361 , Issue.18 , pp. 1776-1785
    • Glass, R.I.1    Parashar, U.D.2    Estes, M.K.3
  • 4
    • 78649863790 scopus 로고    scopus 로고
    • An intranasally delivered Tlr7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles
    • December
    • Velasquez L.S., Hjelm B.E., Arntzen C.J., Herbst-Kralovetz M.M. An intranasally delivered Tlr7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clin Vaccine Immunol 2010, 17(December (12)):1850-1858.
    • (2010) Clin Vaccine Immunol , vol.17 , Issue.12 , pp. 1850-1858
    • Velasquez, L.S.1    Hjelm, B.E.2    Arntzen, C.J.3    Herbst-Kralovetz, M.M.4
  • 5
    • 0034802009 scopus 로고    scopus 로고
    • Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses
    • October
    • Guerrero R.A., Ball J.M., Krater S.S., Pacheco S.E., Clements J.D., Estes M.K. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol 2001, 75(October (20)):9713-9722.
    • (2001) J Virol , vol.75 , Issue.20 , pp. 9713-9722
    • Guerrero, R.A.1    Ball, J.M.2    Krater, S.S.3    Pacheco, S.E.4    Clements, J.D.5    Estes, M.K.6
  • 6
    • 0029891823 scopus 로고    scopus 로고
    • Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice
    • May
    • Mason H.S., Ball J.M., Shi J.J., Jiang X., Estes M.K., Arntzen C.J. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci U S A 1996, 93(May (11)):5335-5340.
    • (1996) Proc Natl Acad Sci U S A , vol.93 , Issue.11 , pp. 5335-5340
    • Mason, H.S.1    Ball, J.M.2    Shi, J.J.3    Jiang, X.4    Estes, M.K.5    Arntzen, C.J.6
  • 7
    • 0031906229 scopus 로고    scopus 로고
    • Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice
    • February
    • Ball J.M., Hardy M.E., Atmar R.L., Conner M.E., Estes M.K. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol 1998, 72(February (2)):1345-1353.
    • (1998) J Virol , vol.72 , Issue.2 , pp. 1345-1353
    • Ball, J.M.1    Hardy, M.E.2    Atmar, R.L.3    Conner, M.E.4    Estes, M.K.5
  • 10
  • 11
    • 0013651896 scopus 로고    scopus 로고
    • Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes
    • July
    • Tacket C.O., Mason H.S., Losonsky G., Estes M.K., Levine M.M., Arntzen C.J. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 2000, 182(July (1)):302-305.
    • (2000) J Infect Dis , vol.182 , Issue.1 , pp. 302-305
    • Tacket, C.O.1    Mason, H.S.2    Losonsky, G.3    Estes, M.K.4    Levine, M.M.5    Arntzen, C.J.6
  • 12
    • 78649587261 scopus 로고    scopus 로고
    • Adjuvanted intranasal norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues
    • December
    • El-Kamary S.S., Pasetti M.F., Mendelman P.M., Frey S.E., Bernstein D.I., Treanor J.J., et al. Adjuvanted intranasal norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010, 202(December (11)):1649-1658.
    • (2010) J Infect Dis , vol.202 , Issue.11 , pp. 1649-1658
    • El-Kamary, S.S.1    Pasetti, M.F.2    Mendelman, P.M.3    Frey, S.E.4    Bernstein, D.I.5    Treanor, J.J.6
  • 13
    • 0027240069 scopus 로고
    • Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations
    • August
    • Green K.Y., Lew J.F., Jiang X., Kapikian A.Z., Estes M.K. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol 1993, 31(August (8)):2185-2191.
    • (1993) J Clin Microbiol , vol.31 , Issue.8 , pp. 2185-2191
    • Green, K.Y.1    Lew, J.F.2    Jiang, X.3    Kapikian, A.Z.4    Estes, M.K.5
  • 14
    • 77957005956 scopus 로고    scopus 로고
    • Serological correlate of protection against norovirus-induced gastroenteritis
    • October
    • Reeck A., Kavanagh O., Estes M.K., Opekun A.R., Gilger M.A., Graham D.Y., et al. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis 2010, 202(October (8)):1212-1218.
    • (2010) J Infect Dis , vol.202 , Issue.8 , pp. 1212-1218
    • Reeck, A.1    Kavanagh, O.2    Estes, M.K.3    Opekun, A.R.4    Gilger, M.A.5    Graham, D.Y.6
  • 15
    • 0034102041 scopus 로고    scopus 로고
    • Vaccines for mucosal immunity to combat emerging infectious diseases
    • March-April
    • van Ginkel F.W., Nguyen H.H., McGhee J.R. Vaccines for mucosal immunity to combat emerging infectious diseases. Emerg Infect Dis 2000, 6(March-April (2)):123-132.
    • (2000) Emerg Infect Dis , vol.6 , Issue.2 , pp. 123-132
    • van Ginkel, F.W.1    Nguyen, H.H.2    McGhee, J.R.3
  • 16
    • 17644371966 scopus 로고    scopus 로고
    • Mucosal immunity and vaccines
    • April
    • Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11(April (4 Suppl)):S45-53.
    • (2005) Nat Med , vol.11 , Issue.4 SUPPL
    • Holmgren, J.1    Czerkinsky, C.2
  • 17
    • 0038330428 scopus 로고    scopus 로고
    • Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA
    • April
    • Holmgren J., Harandi A.M., Czerkinsky C. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Expert Rev Vaccines 2003, 2(April (2)):205-217.
    • (2003) Expert Rev Vaccines , vol.2 , Issue.2 , pp. 205-217
    • Holmgren, J.1    Harandi, A.M.2    Czerkinsky, C.3
  • 18
    • 68049124726 scopus 로고    scopus 로고
    • Mucosal vaccines: novel advances in technology and delivery
    • August
    • Yuki Y., Kiyono H. Mucosal vaccines: novel advances in technology and delivery. Expert Rev Vaccines 2009, 8(August (8)):1083-1097.
    • (2009) Expert Rev Vaccines , vol.8 , Issue.8 , pp. 1083-1097
    • Yuki, Y.1    Kiyono, H.2
  • 19
    • 67649298021 scopus 로고    scopus 로고
    • Delivery strategies to enhance mucosal vaccination
    • April
    • Chadwick S., Kriegel C., Amiji M. Delivery strategies to enhance mucosal vaccination. Expert Opin Biol Ther 2009, 9(April (4)):427-440.
    • (2009) Expert Opin Biol Ther , vol.9 , Issue.4 , pp. 427-440
    • Chadwick, S.1    Kriegel, C.2    Amiji, M.3
  • 20
    • 47349113115 scopus 로고    scopus 로고
    • M cell-targeted delivery of vaccines and therapeutics
    • June
    • Kuolee R., Chen W. M cell-targeted delivery of vaccines and therapeutics. Expert Opin Drug Deliv 2008, 5(June (6)):693-702.
    • (2008) Expert Opin Drug Deliv , vol.5 , Issue.6 , pp. 693-702
    • Kuolee, R.1    Chen, W.2
  • 21
    • 77955882730 scopus 로고    scopus 로고
    • Mucosal delivery of human papillomavirus pseudovirus-encapsidated plas- 765 mids improves the potency of DNA vaccination
    • Graham B.S., Kines R.C., Corbett K.S., Nicewonger J., Johnson T.R., Chen M., et al. Mucosal delivery of human papillomavirus pseudovirus-encapsidated plas- 765 mids improves the potency of DNA vaccination. Mucosal Immunol 2010, 3(5):475-486.
    • (2010) Mucosal Immunol , vol.3 , Issue.5 , pp. 475-486
    • Graham, B.S.1    Kines, R.C.2    Corbett, K.S.3    Nicewonger, J.4    Johnson, T.R.5    Chen, M.6
  • 22
    • 77955288601 scopus 로고    scopus 로고
    • Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B using a piglet model
    • Inskeep T.K., Stahl C., Odle J., Oakes J., Hudson L., Bost K.L., et al. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B using a piglet model. Clin Vaccine Immunol. 2010, 17(8):1163-1169.
    • (2010) Clin Vaccine Immunol. , vol.17 , Issue.8 , pp. 1163-1169
    • Inskeep, T.K.1    Stahl, C.2    Odle, J.3    Oakes, J.4    Hudson, L.5    Bost, K.L.6
  • 23
    • 62249122455 scopus 로고    scopus 로고
    • Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles
    • April
    • Fraillery D., Zosso N., Nardelli-Haefliger D. Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles. Vaccine 2009, 27(April (17)):2326-2334.
    • (2009) Vaccine , vol.27 , Issue.17 , pp. 2326-2334
    • Fraillery, D.1    Zosso, N.2    Nardelli-Haefliger, D.3
  • 24
    • 77954758686 scopus 로고    scopus 로고
    • Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx
    • July
    • Noda K., Kodama S., Umemoto S., Abe N., Hirano T., Suzuki M. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx. Vaccine. 2010, 28(July (31)):5068-5074.
    • (2010) Vaccine. , vol.28 , Issue.31 , pp. 5068-5074
    • Noda, K.1    Kodama, S.2    Umemoto, S.3    Abe, N.4    Hirano, T.5    Suzuki, M.6
  • 25
    • 77957327721 scopus 로고    scopus 로고
    • The mucosal immune response to plant-derived vaccines
    • Hefferon K.L. The mucosal immune response to plant-derived vaccines. Pharm Res 2010, 27(10):2040-2042.
    • (2010) Pharm Res , vol.27 , Issue.10 , pp. 2040-2042
    • Hefferon, K.L.1
  • 26
    • 77953121507 scopus 로고    scopus 로고
    • Simian recombinant adenovirus delivered by the mucosal route modulates gamma-delta T cells from murine genital tract
    • June
    • Lanza S.R., Menin A., Ertl H.C., Bafica A., Pinto A.R. Simian recombinant adenovirus delivered by the mucosal route modulates gamma-delta T cells from murine genital tract. Vaccine 2010, 28(June (29)):4600-4608.
    • (2010) Vaccine , vol.28 , Issue.29 , pp. 4600-4608
    • Lanza, S.R.1    Menin, A.2    Ertl, H.C.3    Bafica, A.4    Pinto, A.R.5
  • 27
    • 8144226081 scopus 로고    scopus 로고
    • A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats
    • December
    • Huang J., Garmise R.J., Crowder T.M., Mar K., Hwang C.R., Hickey A.J., et al. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine 2004, 23(December (6)):794-801.
    • (2004) Vaccine , vol.23 , Issue.6 , pp. 794-801
    • Huang, J.1    Garmise, R.J.2    Crowder, T.M.3    Mar, K.4    Hwang, C.R.5    Hickey, A.J.6
  • 28
    • 35448931929 scopus 로고    scopus 로고
    • Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination
    • Garmise R.J., Staats H.F., Hickey A.J. Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. AAPS PharmSciTech 2007, 8(4):E81.
    • (2007) AAPS PharmSciTech , vol.8 , Issue.4
    • Garmise, R.J.1    Staats, H.F.2    Hickey, A.J.3
  • 29
    • 3542998669 scopus 로고    scopus 로고
    • Nasal route and drug delivery systems
    • June
    • Turker S., Onur E., Ozer Y. Nasal route and drug delivery systems. Pharm World Sci 2004, 26(June (3)):137-142.
    • (2004) Pharm World Sci , vol.26 , Issue.3 , pp. 137-142
    • Turker, S.1    Onur, E.2    Ozer, Y.3
  • 30
    • 77249166118 scopus 로고    scopus 로고
    • The application of mucoadhesive polymers in nasal drug delivery
    • March
    • Jiang L., Gao L., Wang X., Tang L., Ma J. The application of mucoadhesive polymers in nasal drug delivery. Drug Dev Ind Pharm 2010, 36(March (3)):323-336.
    • (2010) Drug Dev Ind Pharm , vol.36 , Issue.3 , pp. 323-336
    • Jiang, L.1    Gao, L.2    Wang, X.3    Tang, L.4    Ma, J.5
  • 31
    • 0023243066 scopus 로고
    • The common mucosal immune system and current strategies for induction of immune responses in external secretions
    • July
    • Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol 1987, 7(July (4)):265-276.
    • (1987) J Clin Immunol , vol.7 , Issue.4 , pp. 265-276
    • Mestecky, J.1
  • 32
    • 67149120680 scopus 로고    scopus 로고
    • Dry powder nasal vaccines as an alternative to needle-based delivery
    • Hickey A.J., Garmise R.J. Dry powder nasal vaccines as an alternative to needle-based delivery. Crit Rev Ther Drug Carrier Syst 2009, 26(1):1-27.
    • (2009) Crit Rev Ther Drug Carrier Syst , vol.26 , Issue.1 , pp. 1-27
    • Hickey, A.J.1    Garmise, R.J.2
  • 33
    • 0032702094 scopus 로고    scopus 로고
    • Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
    • December
    • Treanor J.J., Kotloff K., Betts R.F., Belshe R., Newman F., Iacuzio D., et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 1999, 18(December (9-10)):899-906.
    • (1999) Vaccine , vol.18 , Issue.9-10 , pp. 899-906
    • Treanor, J.J.1    Kotloff, K.2    Betts, R.F.3    Belshe, R.4    Newman, F.5    Iacuzio, D.6
  • 34
    • 0033554086 scopus 로고    scopus 로고
    • Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial
    • July
    • Nichol K.L., Mendelman P.M., Mallon K.P., Jackson L.A., Gorse G.J., Belshe R.B., et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999, 282(July (2)):137-144.
    • (1999) JAMA , vol.282 , Issue.2 , pp. 137-144
    • Nichol, K.L.1    Mendelman, P.M.2    Mallon, K.P.3    Jackson, L.A.4    Gorse, G.J.5    Belshe, R.B.6
  • 35
    • 0032516267 scopus 로고    scopus 로고
    • The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
    • May
    • Belshe R.B., Mendelman P.M., Treanor J., King J., Gruber W.C., Piedra P., et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998, 338(May (20)):1405-1412.
    • (1998) N Engl J Med , vol.338 , Issue.20 , pp. 1405-1412
    • Belshe, R.B.1    Mendelman, P.M.2    Treanor, J.3    King, J.4    Gruber, W.C.5    Piedra, P.6
  • 36
    • 0035940309 scopus 로고    scopus 로고
    • Nasal vaccines
    • September (1-3)
    • Davis S.S. Nasal vaccines. Adv Drug Deliv Rev 2001, 51(September (1-3)):21-42.
    • (2001) Adv Drug Deliv Rev , vol.51 , pp. 21-42
    • Davis, S.S.1
  • 37
    • 18744368156 scopus 로고    scopus 로고
    • Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation
    • June 11
    • Buonaguro L., Visciano M.L., Tornesello M.L., Tagliamonte M., Biryahwaho B., Buonaguro F.M. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation. J Virol 2005, 79(June 11):7059-7067.
    • (2005) J Virol , vol.79 , pp. 7059-7067
    • Buonaguro, L.1    Visciano, M.L.2    Tornesello, M.L.3    Tagliamonte, M.4    Biryahwaho, B.5    Buonaguro, F.M.6
  • 38
    • 0031668082 scopus 로고    scopus 로고
    • Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
    • October
    • Balmelli C., Roden R., Potts A., Schiller J., De Grandi P., Nardelli-Haefliger D. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J Virol 1998, 72(October (10)):8220-8229.
    • (1998) J Virol , vol.72 , Issue.10 , pp. 8220-8229
    • Balmelli, C.1    Roden, R.2    Potts, A.3    Schiller, J.4    De Grandi, P.5    Nardelli-Haefliger, D.6
  • 39
    • 0032826809 scopus 로고    scopus 로고
    • Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice
    • November
    • Nardelli-Haefliger D., Roden R., Balmelli C., Potts A., Schiller J., De Grandi P. Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice. J Virol 1999, 73(November (11)):9609-9613.
    • (1999) J Virol , vol.73 , Issue.11 , pp. 9609-9613
    • Nardelli-Haefliger, D.1    Roden, R.2    Balmelli, C.3    Potts, A.4    Schiller, J.5    De Grandi, P.6
  • 42
    • 55049117526 scopus 로고    scopus 로고
    • Mucoadhesive microspheres: a promising tool in drug delivery
    • October
    • Patil S.B., Sawant K.K. Mucoadhesive microspheres: a promising tool in drug delivery. Curr Drug Deliv 2008, 5(October (4)):312-318.
    • (2008) Curr Drug Deliv , vol.5 , Issue.4 , pp. 312-318
    • Patil, S.B.1    Sawant, K.K.2
  • 43
    • 77950666776 scopus 로고    scopus 로고
    • Evaluation of mucoadhesive PLGA microparticles for nasal immunization
    • June
    • Pawar D., Goyal A.K., Mangal S., Mishra N., Vaidya B., Tiwari S., et al. Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J 2010, 12(June (2)):130-137.
    • (2010) AAPS J , vol.12 , Issue.2 , pp. 130-137
    • Pawar, D.1    Goyal, A.K.2    Mangal, S.3    Mishra, N.4    Vaidya, B.5    Tiwari, S.6
  • 44
    • 77249166118 scopus 로고    scopus 로고
    • The application of mucoadhesive polymers in nasal drug delivery
    • March
    • Jiang L., Gao L., Wang X., Tang L., Ma J. The application of mucoadhesive polymers in nasal drug delivery. Drug Dev Ind Pharm 2010, 36(March (3)):323-336.
    • (2010) Drug Dev Ind Pharm , vol.36 , Issue.3 , pp. 323-336
    • Jiang, L.1    Gao, L.2    Wang, X.3    Tang, L.4    Ma, J.5
  • 45
    • 79960295788 scopus 로고    scopus 로고
    • Inventor in situ gel formation of pectin
    • USA Patent 6,777,000 B2;
    • Ni YaY, KM. Inventor in situ gel formation of pectin. USA Patent 6,777,000 B2; 2004.
    • (2004)
    • Ni YaY, K.M.1
  • 46
    • 14744283794 scopus 로고    scopus 로고
    • Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses
    • March
    • Huang Z., Elkin G., Maloney B.J., Beuhner N., Arntzen C.J., Thanavala Y., et al. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine 2005, 23(March (15)):1851-1858.
    • (2005) Vaccine , vol.23 , Issue.15 , pp. 1851-1858
    • Huang, Z.1    Elkin, G.2    Maloney, B.J.3    Beuhner, N.4    Arntzen, C.J.5    Thanavala, Y.6
  • 47
    • 40849140609 scopus 로고    scopus 로고
    • An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles
    • March
    • Santi L., Batchelor L., Huang Z., Hjelm B., Kilbourne J., Arntzen C.J., et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26(March (15)):1846-1854.
    • (2008) Vaccine , vol.26 , Issue.15 , pp. 1846-1854
    • Santi, L.1    Batchelor, L.2    Huang, Z.3    Hjelm, B.4    Kilbourne, J.5    Arntzen, C.J.6
  • 48
    • 0015384219 scopus 로고
    • Quantitative composition of nasal secretions in normal subjects
    • August
    • Lorin M.I., Gaerlan P.F., Mandel I.D. Quantitative composition of nasal secretions in normal subjects. J Lab Clin Med 1972, 80(August (2)):275-281.
    • (1972) J Lab Clin Med , vol.80 , Issue.2 , pp. 275-281
    • Lorin, M.I.1    Gaerlan, P.F.2    Mandel, I.D.3
  • 49
    • 77952668173 scopus 로고    scopus 로고
    • A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation
    • June
    • Saluja V., Amorij J.P., Kapteyn J.C., de Boer A.H., Frijlink H.W., Hinrichs W.L. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. J Control Release 2010, 144(June (2)):127-133.
    • (2010) J Control Release , vol.144 , Issue.2 , pp. 127-133
    • Saluja, V.1    Amorij, J.P.2    Kapteyn, J.C.3    de Boer, A.H.4    Frijlink, H.W.5    Hinrichs, W.L.6
  • 50
    • 0019824013 scopus 로고
    • Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis
    • September
    • Rutland J., Cole P.J. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis. Thorax 1981, 36(September (9)):654-658.
    • (1981) Thorax , vol.36 , Issue.9 , pp. 654-658
    • Rutland, J.1    Cole, P.J.2
  • 51
    • 77956193139 scopus 로고    scopus 로고
    • Evaluation of ISCOM matrices clearance from rabbit nasal cavity by gamma scintigraphy
    • October (1-2)
    • Pandey R.S., Babbar A.K., Kaul A., Mishra A.K., Dixit V.K. Evaluation of ISCOM matrices clearance from rabbit nasal cavity by gamma scintigraphy. Int J Pharm 2010, 398(October (1-2)):231-236.
    • (2010) Int J Pharm , vol.398 , pp. 231-236
    • Pandey, R.S.1    Babbar, A.K.2    Kaul, A.3    Mishra, A.K.4    Dixit, V.K.5
  • 52
    • 79960314952 scopus 로고    scopus 로고
    • Inventor delivery of physiological agents with in-situ gels comprising anionic polysaccharides
    • USA Patent 7,494,669.
    • Ni YaY, KM. Inventor delivery of physiological agents with in-situ gels comprising anionic polysaccharides. USA Patent 7,494,669; 2009.
    • (2009)
    • Ni YaY, K.M.1
  • 53
    • 9244265493 scopus 로고    scopus 로고
    • Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
    • January
    • Alpar H.O., Somavarapu S., Atuah K.N., Bramwell V.W. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliv Rev 2005, 57(January (3)):411-430.
    • (2005) Adv Drug Deliv Rev , vol.57 , Issue.3 , pp. 411-430
    • Alpar, H.O.1    Somavarapu, S.2    Atuah, K.N.3    Bramwell, V.W.4
  • 54
    • 0035869132 scopus 로고    scopus 로고
    • Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment
    • March
    • Bernstein D.I., Harrison C.J., Tomai M.A., Miller R.L. Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. J Infect Dis 2001, 183(March (6)):844-849.
    • (2001) J Infect Dis , vol.183 , Issue.6 , pp. 844-849
    • Bernstein, D.I.1    Harrison, C.J.2    Tomai, M.A.3    Miller, R.L.4
  • 55
    • 0028835820 scopus 로고
    • Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs
    • January
    • Bernstein D.I., Harrison C.J., Tepe E.R., Shahwan A., Miller R.L. Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs. Vaccine 1995, 13(January (1)):72-76.
    • (1995) Vaccine , vol.13 , Issue.1 , pp. 72-76
    • Bernstein, D.I.1    Harrison, C.J.2    Tepe, E.R.3    Shahwan, A.4    Miller, R.L.5
  • 56
    • 33646126484 scopus 로고    scopus 로고
    • An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits
    • May
    • Wimer-Mackin S., Hinchcliffe M., Petrie C.R., Warwood S.J., Tino W.T., Williams M.S., et al. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Vaccine 2006, 24(May (18)):3953-3963.
    • (2006) Vaccine , vol.24 , Issue.18 , pp. 3953-3963
    • Wimer-Mackin, S.1    Hinchcliffe, M.2    Petrie, C.R.3    Warwood, S.J.4    Tino, W.T.5    Williams, M.S.6
  • 57
    • 77949415982 scopus 로고    scopus 로고
    • Preparation and in vivo study of dry powder microspheres for nasal immunization
    • April
    • Tafaghodi M., Rastegar S. Preparation and in vivo study of dry powder microspheres for nasal immunization. J Drug Target 2010, 18(April (3)):235-242.
    • (2010) J Drug Target , vol.18 , Issue.3 , pp. 235-242
    • Tafaghodi, M.1    Rastegar, S.2
  • 58
    • 67349128324 scopus 로고    scopus 로고
    • Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
    • May
    • Baldwin S.L., Bertholet S., Kahn M., Zharkikh I., Ireton G.C., Vedvick T.S., et al. Intradermal immunization improves protective efficacy of a novel TB vaccine candidate. Vaccine 2009, 27(May (23)):3063-3071.
    • (2009) Vaccine , vol.27 , Issue.23 , pp. 3063-3071
    • Baldwin, S.L.1    Bertholet, S.2    Kahn, M.3    Zharkikh, I.4    Ireton, G.C.5    Vedvick, T.S.6
  • 59
    • 77953483935 scopus 로고    scopus 로고
    • Assessing the immunopotency of toll-like receptor agonists in an in vitro tissue-engineered immunological model
    • July
    • Ma Y., Poisson L., Sanchez-Schmitz G., Pawar S., Qu C., Randolph G.J., et al. Assessing the immunopotency of toll-like receptor agonists in an in vitro tissue-engineered immunological model. Immunology 2010, 130(July (3)):374-387.
    • (2010) Immunology , vol.130 , Issue.3 , pp. 374-387
    • Ma, Y.1    Poisson, L.2    Sanchez-Schmitz, G.3    Pawar, S.4    Qu, C.5    Randolph, G.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.